Literature DB >> 22079

Human leukocytic pyrogen: purification and development of a radioimmunoassay.

C A Dinarello, L Renfer, S M Wolff.   

Abstract

Leukocytic pyrogen is a small endogenous protein that mediates fever. Because of the limitations of bioassays, circulating leukocytic pyrogen has not been demonstrated during fever in humans. The pyrogen was produced in vitro after phagocytosis of staphylococci by blood monocytes. Antibody against the pyrogen was obtained from rabbits immunized with leukocytic pyrogen and the antiserum was purified by solid-phase immunoadsorbants. Purified antibody to the pyrogen was attached to activated Sepharose 4B and used in conjunction with gel filtration to purify the pyrogen. The pyrogen was labeled with 125I and further purified by gel filtration and ion-exchange chromatography. The final preparation of 125I-labeled pyrogen demonstrated a homogeneous band during isoelectric focusing and other separation procedures. With antibody to pyrogen attached to Sepharose, less than 0.1 of a rabbit pyrogenic dose of human leukocytic pyrogen inhibited the binding of 125I-labeled pyrogen to this immunoadsorbant, and this inhibition was not affected by the presence of human serum. Thus, a radioimmunoassay for human leukocytic pyrogen has been developed that may be used to detect circulating pyrogen during fever in humans.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 22079      PMCID: PMC431999          DOI: 10.1073/pnas.74.10.4624

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

Review 1.  Fever.

Authors:  E Atkins; P Bodel
Journal:  N Engl J Med       Date:  1972-01-06       Impact factor: 91.245

2.  Factors affecting the quantitative production and assay of human leukocytic pyrogen.

Authors:  R K Root; J J Nordlund; S M Wolff
Journal:  J Lab Clin Med       Date:  1970-04

3.  Selective enzyme purification by affinity chromatography.

Authors:  P Cuatrecasas; M Wilchek; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

4.  Transferable pyrogen in human experimental fever.

Authors:  M D Rawlins; W I Cranston; R H Luff
Journal:  Clin Sci       Date:  1971-02       Impact factor: 6.124

5.  On the demonstration of circulating human endogenous pyrogen.

Authors:  S E Greisman; R B Hornick
Journal:  Proc Soc Exp Biol Med       Date:  1972-02

6.  Human leukocyte pyrogen producing fever in rabbits.

Authors:  P Bodel; E Atkins
Journal:  Proc Soc Exp Biol Med       Date:  1966-03

7.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

8.  The production of antibody against human leukocytic pyrogen.

Authors:  C A Dinarello; L Renfer; S M Wolff
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

9.  Demonstration and characterization of two distinct human leukocytic pyrogens.

Authors:  C A Dinarello; N P Goldin; S M Wolff
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

10.  Studies on the origin of human leukocytic pyrogen.

Authors:  J J Nordlund; R K Root; S M Wolff
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

  10 in total
  65 in total

Review 1.  Blocking interleukin-1β in acute and chronic autoinflammatory diseases.

Authors:  C A Dinarello
Journal:  J Intern Med       Date:  2011-01       Impact factor: 8.989

2.  Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha.

Authors:  P Busson; K Braham; G Ganem; F Thomas; D Grausz; M Lipinski; H Wakasugi; T Tursz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

3.  Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies.

Authors:  M Lotz; C D Tsoukas; C A Robinson; C A Dinarello; D A Carson; J H Vaughan
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 4.  Historical insights into cytokines.

Authors:  Charles A Dinarello
Journal:  Eur J Immunol       Date:  2007-11       Impact factor: 5.532

Review 5.  Interleukin-1 and the effects of cyclooxygenase inhibitors on its biological activities.

Authors:  C A Dinarello
Journal:  Bull N Y Acad Med       Date:  1989-01

6.  Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor.

Authors:  Eli C Lewis; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

7.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

Authors:  J A Schmidt; C N Oliver; J L Lepe-Zuniga; I Green; I Gery
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

Review 8.  Interleukin-1 function and role in rheumatic disease.

Authors:  Georg Schett; Jean-Michel Dayer; Bernhard Manger
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

9.  Human leukocytic pyrogen induces release of specific granule contents from human neutrophils.

Authors:  M S Klempner; C A Dinarello; J I Gallin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

10.  Antibodies of predetermined specificity to the major charged species of human interleukin 1.

Authors:  G Limjuco; S Galuska; J Chin; P Cameron; J Boger; J A Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.